Our team of world-leading experts in endospore research and manipulation provide an unsurpassed capability that combines the disciplines of organic chemistry, biochemistry and microbiology and animal models of disease.
Able Therapeutics has partnered with UNLV to apply research developed in its labs in the commercial arena. Solutions to help manage urgent human and animal health challenges are now within reach.
An extraordinary group of industry veterans with experience in commercial, operational, clinical, scientific and IP arenas within the biotech and pharma space have been convened to contribute to Able Therapeutics' important work in development and commercialization of its products.